Success model results for the newest family relations between mammographic occurrence and exposure from breast cancer demise, stratified by the cyst qualities, AJCC stages I–IV mutual*
* Fully adjusted model includes covariates for AJCC stage (I, IIA, IIB, III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), body mass index (18.5 – <25, 25 – <30, ?30kg/m 2 ), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded. AJCC = American Joint Committee on Cancer; BI-RADS = Breast Imaging Reporting and Data System; CI = confidence interval; ER = estrogen receptor; HR = hazard ratio; PR = progesterone receptor.
† P-well worth off Wald statistic to check getting an overall total aftereffect of categorical BI-RADS occurrence. The statistical examination have been one or two-sided.
N = 96 lady excluded regarding end in-certain activities
007); specifically, elevated risk associated with having almost entirely fatty breasts was apparent for obese women (BMI ?30kg/m 2 , HR = 2.02, 95% CI = 1.37 to 2.97) but not overweight (BMI 25 – <30kg/m 2 , HR = 0.70, 95% CI = 0.40 to 1.23) or lean (BMI 18.5 – <25kg/m 2 , HR = 1.27, 95% CI = 0.74 to 2.17) women. To determine whether this association was being driven by a subgroup of women who were morbidly obese (BMI ?40kg/m 2 ), we conducted post hoc analyses after excluding 313 morbidly obese women, of whom 47 died of breast cancer. In BMI-stratified results, the elevated risk associated with having almost entirely fatty breasts remained apparent for obese women (BMI 30 – <40kg/m 2 , HR = 1.68, 95% CI = 1.07 to 2.63), and the interaction between breast density and BMI was still statistically significant (P = .01).
We found a mathematically tall telecommunications between Body mass index and you will BI-RADS occurrence in terms of breast cancer dying (P to possess communications =
* BI-RADS, Nipple Imaging Reporting and you will Investigation System; Body mass index, body mass index; CI, trust period; Time, possibility ratio. All cancers: Body mass index ? occurrence communication, P = .007.
† Fully adjusted model includes covariates for American Joint Committee on Cancer stage (I, IIA, IIB, eharmony III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded.
‡ P worth off Wald figure to check on having an overall effect from categorical BI-RADS thickness. All statistical testing was several-sided.
We found a statistically high interaction ranging from Bmi and you may BI-RADS density when it comes to cancer of the breast death (P to have telecommunications =
* BI-RADS, Nipple Imaging Reporting and you can Study System; Bmi, bmi; CI, depend on period; Time, threat ratio. Every tumors: Body mass index ? density interaction, P = .007.
† Fully adjusted model includes covariates for American Joint Committee on Cancer stage (I, IIA, IIB, III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded.